Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software, Services), Technique (ELISA, Rapid Test), Application (Infectious Diseases, Endocrinology, Oncology), End User (Clinical Labs, Hospitals) - Global Forecast to 2021

The global immunoassay market is expected to reach USD 25.45 Billion by 2021 from USD 17.16 Billion in 2016 at a CAGR of 8.2%. The global market is broadly classified into product & service, technology, application, end user, and region.

On the basis of product & service, the immunoassay market is segmented into, analyzers, and software and services. The reagents & kits segment is expected to account for the largest share of the global immunoassay market in 2016. Reagents & kits account for the largest share of the immunoassay products market owing to the rise in the number of immunoassay tests due to the increase in aging population, rising prevalence of chronic and infectious diseases and increased variety of reagents and analytical techniques employed. Companies invest in R&D activities to enhance their product offerings and expand their market share. For instance, in August 2016, Alere Inc. opened a new diagnostics manufacturing facility in India. The new factory produces rapid tests for the detection of infectious diseases. In July 2015, Sysmex expanded its reagent factory in Germany to meet the expected increase in demand for reagents in the EMEA (Europe, the Middle East, and Africa region. The reagents & kits segment is further divided into ELISA, rapid tests reagents, western blot reagents, ELISPOT reagents, RIA reagents, and PCR reagents. The analyzers segment is further divided into purchase mode and type. Based on purchase mode, analyzers market is segmented into reagent rental purchase and outright purchase and on the basis of type, these are divided into open-end systems and closed-ended systems.
Based on technology, the immunoassay market is segmented into ELISA, rapid tests, western blot tests, ELISPOT, RIA, and PCR. The ELISA segment is further divided into platform and generation. On the basis of platform, the ELISA market is divided into CLIA, FIA, and CI. On the basis of generation, the ELISA market is further divided into first generation, second generation, third generation, and fourth generation & above.

Applications, included in the immunoassay market are infectious diseases, endocrinology, bone and mineral disorders, oncology, cardiology, hematology and blood screening, autoimmune diseases, toxicology, neonatal screening, and other applications. The infectious diseases segment is expected to account for the largest share of the global immunoassay market in 2016. The rise in incidence of HIV, tuberculosis, hepatitis, and other hospital-acquired infections has fueled the demand for immunoassay tests.

Based on end user, the immunoassay market is segmented into hospitals, clinical laboratories, blood banks, research & academic laboratories, pharmaceutical companies, CROs, biotechnology companies, and other end users. The hospital segment is expected to account for the largest share of the global immunoassay market in 2016 owing to the growth in public healthcare awareness and increasing affordability of treatments.

Geographically, the immunoassay market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing incidence of chronic diseases in the North American countries. According to the American Medical Association and the American Medical Group Association, more than 50% of Americans suffered from one or more chronic diseases in 2012; the number of Americans suffering from chronic diseases was around 133 million in 2005 and this figure is expected to reach around 157 million by 2020. With this significant growth in the number of patients suffering from chronic diseases, the market for immunoassay is expected to grow in this region in the coming years.

The major players in the immunoassay market are F. Hoffmann-La Roche Ltd. (Switzerland), Siemens AG (Germany), Abbott Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Ortho-Clinical Diagnostics, Inc. (U.S.), and bioMιrieux SA (France).

Target Audience for this Report:

• Immunoassay Manufacturers
• In Vitro Diagnostic (IVD) Products Manufacturers
• Immunoassay Distributors and Wholesalers
• OEM (Original Equipment Manufacturers)/Contract Manufacturers
• Diagnostic Associations
• Clinical Laboratories and Hospitals
• Various Research and Consulting Firms
• Research Institutes
• Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
• Pharmaceutical and Biopharmaceutical Players

Value Addition for the Buyer:

This report aims to provide insights into the global immunoassay market. It provides valuable information on the product & service, technology, application, end user, and region in the immunoassay market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

The above-mentioned information would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This report categorizes the immunoassay market into the following segments:

Global Immunoassay Market, by Product & Service

• Reagents & Kits
  • Reagents & Kits, by Type
    • Enzyme-linked Immunosorbent Assay (ELISA)
    • Rapid Test Reagents
    • Western Blot Reagents
    • ELISPOT Reagents
    • RIA Reagents
    • PCR Reagents
• Analyzers
  • Analyzers, By Purchase Mode
    • Reagent Rental Purchase
    • Outright Purchase
  • Analyzers, By Type
    • Open-ended Systems
    • Closed-ended Systems
    • Software and Services

Global Immunoassay Market, by Technology

• ELISA
  • By Platform
    • Chemiluminescence Immunoassays (CLIA)
    • Fluorescence Immunoassays (FIA)
    • Colorimetric Immunoassays (CI)
  • By Type
    • First Generation
    • Second Generation
    • Third Generation
    • Fourth Generation and above
• Rapid Tests
• Western Blot
• ELISPOT
• Radioimmunoassays (RIA)
• Polymerase Chain Reaction (PCR)

 Global Immunoassay Market, by Application     

• Infectious Diseases
• Endocrinology
• Bone And Mineral Disorders
• Oncology
• Cardiology
• Hematology And Blood Screening
• Autoimmune Diseases
• Toxicology
• Neonatal Screening
• Other Applications

Global Immunoassay Market, by End User

• Hospitals
• Clinical Laboratories
• Blood Banks
• Research & Academic Laboratories
• Pharmaceutical Companies, CROs, and Biotechnology Companies
• Other End Users

Global Immunoassay Market, by Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Spain
  • RoE
• Asia
  • India
  • China
  • Japan
  • South Korea
  • Taiwan
  • RoA
• Rest of the World (RoW)

Customization Options:

• Company Information: Detailed company profiles of five or more market players
• Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 28)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 33)
    4.1 The Immunoassay Market is Projected to Grow at A Robust Growth Rate From 2016 to 2021
    4.2 Geographic Analysis: Global Immunoassay Market, By Product and Service
    4.3 Global Immunoassay Market, By Technology
    4.4 Geographical Snapshot of the Global Market
    4.5 Global Market, By Application
    4.6 Global Market, By End User
    4.7 Lifecycle Analysis, By Region

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Immunoassay Market: Drivers, Restraints, Opportunities, and Challenges
           5.2.2 Drivers
                    5.2.2.1 Growing Prevalence of Infectious and Chronic Diseases
                    5.2.2.2 Extensive Use of Immunoassay in Oncology
                    5.2.2.3 Technological Advancements
                    5.2.2.4 Cost-Effectiveness & Rapid Analysis
                    5.2.2.5 Growth in the Biotechnology and Pharmaceutical Sector
           5.2.3 Restraints
                    5.2.3.1 Low Detection Limit of Immunoassay
                    5.2.3.2 Implementation of Excise Duty By the U.S. Government
                    5.2.3.3 Stringent Regulations
           5.2.4 Opportunities
                    5.2.4.1 Integration of Microfluidics in Immunoassay
                    5.2.4.2 Point-Of-Care Testing With Multiplex Assay
                    5.2.4.3 Emerging Economies
           5.2.5 Challenges
                    5.2.5.1 Pricing Pressure on Manufacturers

6 Immunoassay Market, By Technology (Page No. - 46)
    6.1 Introduction
    6.2 Enzyme-Linked Immunosorbent Assay (ELISA)
           6.2.1 ELISA Market, By Platform
                    6.2.1.1 Chemiluminescence Immunoassay (CLIA)
                    6.2.1.2 Fluorescence Immunoassay (FIA)
                    6.2.1.3 Colorimetric Immunoassay (CI)
           6.2.2 ELISA Market, By Type
                    6.2.2.1 First Generation
                    6.2.2.2 Second Generation
                    6.2.2.3 Third Generation
                    6.2.2.4 Fourth Generation and Above
    6.3 Rapid Tests
    6.4 Western Blot
    6.5 Elispot
    6.6 Radioimmunoassay (RIA)
    6.7 Polymerase Chain Reaction (PCR)

7 Immunoassay Market, By Product and Service (Page No. - 63)
    7.1 Introduction
    7.2 Reagents & Kits
           7.2.1 By Type
                    7.2.1.1 Enzyme-Linked Immunosorbent Assay (ELISA) Reagents and Kits
                    7.2.1.2 Rapid Test Reagents and Kits
                    7.2.1.3 Western Blot Reagents and Kits
                    7.2.1.4 Elispot Reagents and Kits
                    7.2.1.5 RIA Reagents and Kits
                    7.2.1.6 PCR Reagents and Kits
    7.3 Analyzers
           7.3.1 By Purchase Mode
                    7.3.1.1 Reagent Rental Purchase
                    7.3.1.2 Outright Purchase
           7.3.2 By Type
                    7.3.2.1 Open-Ended Systems
                    7.3.2.2 Closed-Ended Systems
    7.4 Software and Services

8 Immunoassay Market, By Application (Page No. - 81)
    8.1 Introduction
    8.2 Infectious Diseases
    8.3 Endocrinology
    8.4 Bone and Mineral Disorders
    8.5 Oncology
    8.6 Cardiology
    8.7 Hematology and Blood Screening
    8.8 Autoimmune Disorders
    8.9 Toxicology
    8.10 Neonatal Screening
    8.11 Other Applications

9 Immunoassay Market, By End User (Page No. - 98)
    9.1 Introduction
    9.2 Hospitals
    9.3 Clinical Laboratories
    9.4 Blood Banks
    9.5 Research & Academic Laboratories
    9.6 Pharmaceutical Companies, Cros, and Biotechnology Companies
    9.7 Other End Users

10 Immunoassay Market, By Region (Page No. - 108)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
             10.2.3 Mexico
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe (RoE)
     10.4 Asia
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 South Korea
             10.4.5 Taiwan
             10.4.6 Rest of Asia (RoA)
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 164)
     11.1 Introduction
     11.2 Strategic Overview
     11.3 Market Share Analysis
     11.4 Competitive Situation and Trends
             11.4.1 Agreements, Partnerships, and Collaborations
             11.4.2 Regulatory Approvals
             11.4.3 Expansions
             11.4.4 Product Launches
             11.4.5 Acquisitions

12 Company Profiles (Page No. - 172)
(Overview, Products and Services, Financials, Strategy & Development)*
     12.1 Introduction
     12.2 F. Hoffmann-La Roche Ltd.
     12.3 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
     12.4 Bio-Rad Laboratories, Inc.
     12.5 Siemens AG
     12.6 Sysmex Corporation
     12.7 Biomιrieux Sa
     12.8 Alere Inc.
     12.9 Becton, Dickinson and Company
     12.10 Ortho Clinical Diagnostics, Inc.
     12.11 Abbott Laboratories, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 196)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports

List of Tables (139 Tables)

Table 1 Incidence of Infectious Diseases, 2014-2015
Table 2 Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 3 Market Size for ELISA, By Country, 2014–2021 (USD Million)
Table 4 ELISA Market Size, By Platform, 2014–2021 (USD Million)
Table 5 ELISA Market Size, By Generation, 2014–2021 (USD Million)
Table 6 CLIA Market Size, By Country, 2014–2021 (USD Million)
Table 7 FIA Market Size, By Country, 2014–2021 (USD Million)
Table 8 Colorimetric Immunoassay (CI) Market Size, By Country, 2014–2021 (USD Million)
Table 9 First-Generation ELISA Market Size, By Country, 2014–2021 (USD Million)
Table 10 Second-Generation ELISA Market Size, By Country, 2014–2021 (USD Million)
Table 11 Third-Generation ELISA Market Size, By Country, 2014–2021 (USD Million)
Table 12 Fourth-Generation ELISA Market Size, By Country, 2014–2021 (USD Million)
Table 13 Market Size for Rapid Tests, By Country, 2014–2021 (USD Million)
Table 14 Market Size for Western Blot, By Country, 2014–2021 (USD Million)
Table 15 Market Size for Elispot, By Country, 2014–2021 (USD Million)
Table 16 Market Size for RIA, By Country, 2014–2021 (USD Million)
Table 17 Market Size for Polymerase Chain Reaction (PCR), By Country, 2014–2021 (USD Million)
Table 18 Market Size, By Product & Service, 2014–2021 (USD Million)
Table 19 Immunoassay Reagents & Kits Market Size, By Type, 2014–2021 (USD Million)
Table 20 ELISA Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 21 Rapid Test Reagents and Kits Market Size, By Country, 2014–2021 (USD Million)
Table 22 Western Blot Reagents and Kits Market Size, By Country, 2014–2021 (USD Million)
Table 23 Elispot Reagents and Kits Market Size, By Country, 2014–2021 (USD Million)
Table 24 RIA Reagents and Kits Market Size, By Country, 2014–2021 (USD Million)
Table 25 PCR Reagents and Kits Market Size, By Country, 2014–2021 (USD Million)
Table 26 Immunoassay Analyzers Market Size, By Country, 2014–2021 (USD Million)
Table 27 Immunoassay Analyzers Market Size, By Type, 2014–2021 (USD Million)
Table 28 Immunoassay Analyzers Market Size, By Purchase Mode, 2014–2021 (USD Million)
Table 29 Reagent Rental Purchase Market Size, By Country, 2014–2021 (USD Million)
Table 30 Outright Purchase Market Size, By Country, 2014–2021 (USD Million)
Table 31 Open-Ended Immunoassay Systems Market Size, By Country, 2014–2021 (USD Million)
Table 32 Closed-Ended Immunoassay Systems Market Size, By Country, 2014–2021 (USD Million)
Table 33 Immunoassay Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 34 Market Size, By Application, 2014–2021 (USD Million)
Table 35 Market Size for Infectious Diseases, By Country, 2014–2021 (USD Million)
Table 36 Market Size for Endocrinology, By Country, 2014–2021 (USD Million)
Table 37 Market Size for Bone and Mineral Disorders, By Country, 2014–2021 (USD Million)
Table 38 Market Size for Oncology, By Country, 2014–2021 (USD Million)
Table 39 Market Size for Cardiology, By Country, 2014–2021 (USD Million)
Table 40 Market Size for Hematology and Blood Screening, By Country, 2014–2021 (USD Million)
Table 41 Prevalence of Autoimmune Diseases
Table 42 Market Size for Autoimmune Disorders, By Country, 2014–2021 (USD Million)
Table 43 Immunoassay Market Size for Toxicology, By Country, 2014–2021 (USD Million)
Table 44 Immunoassay Market Size for Neonatal Screening, By Country, 2014–2021 (USD Million)
Table 45 Immunoassay Market Size for Other Applications, By Country, 2014–2021 (USD Million)
Table 46 Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 47 Immunoassay Market Size for Hospitals, By Country, 2014–2021 (USD Million)
Table 48 Immunoassay Market Size for Clinical Laboratories, By Country, 2014–2021 (USD Million)
Table 49 Immunoassay Market Size for Blood Banks, By Country, 2014–2021 (USD Million)
Table 50 Immunoassay Market Size for Research & Academic Laboratories, By Country, 2014–2021 (USD Million)
Table 51 Immunoassay Market Size for Pharmaceutical Companies, Cros, and Biotechnology Companies, By Country, 2014–2021 (USD Million)
Table 52 Immunoassay Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 53 Immunoassay Market Size, By Region, 2014–2021 (USD Million)
Table 54 North America: Immunoassay Market Size, By Country, 2014–2021 (USD Million)
Table 55 Europe: Immunoassay Market Size, By Country, 2014–2021 (USD Million)
Table 56 Asia: Immunoassay Market Size, By Country, 2014–2021 (USD Million)
Table 57 North America: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 58 North America: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 59 North America: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 60 North America: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 61 U.S.: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 62 U.S.: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 63 U.S.: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 64 U.S.: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 65 Canada: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 66 Canada: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 67 Canada: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 68 Canada: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 69 Mexico: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 70 Mexico: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 71 Mexico: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 72 Mexico: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 73 Europe: Immunoassay Market Size, By Country, 2014–2021 (USD Million)
Table 74 Europe: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 75 Europe: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 76 Europe: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 77 Europe: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 78 Germany: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 79 Germany: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 80 Germany: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 81 Germany: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 82 France: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 83 France: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 84 France: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 85 France: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 86 U.K.: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 87 U.K.: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 88 U.K.: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 89 U.K.: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 90 Italy: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 91 Italy: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 92 Italy: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 93 Italy: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 94 Spain: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 95 Spain: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 96 Spain: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 97 Spain: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 98 RoE: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 99 RoE: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 100 RoE: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 101 RoE: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 102 Asia: Immunoassay Market Size, By Country, 2014–2021 (USD Million)
Table 103 Asia: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 104 Asia: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 105 Asia: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 106 Asia: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 107 Japan: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 108 Japan: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 109 Japan: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 110 Japan: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 111 China: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 112 China: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 113 China: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 114 China: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 115 India: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 116 India: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 117 India: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 118 India: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 119 South Korea: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 120 South Korea: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 121 South Korea: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 122 South Korea: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 123 Taiwan: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 124 Taiwan: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 125 Taiwan: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 126 Taiwan: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 127 RoA: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 128 RoA: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 129 RoA: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 130 RoA: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 131 RoW: Immunoassay Market Size, By Technology, 2014–2021 (USD Million)
Table 132 RoW: Immunoassay Market Size, By Product & Service, 2014–2021 (USD Million)
Table 133 RoW: Immunoassay Market Size, By Application, 2014–2021 (USD Million)
Table 134 RoW: Immunoassay Market Size, By End User, 2014–2021 (USD Million)
Table 135 Agreements, Partnerships, and Collaborations, 2014–2016
Table 136 Regulatory Approvals, 2013–2016
Table 137 Expansions, 2015–2016
Table 138 Product Launches, 2015–2016
Table 139 Acquisitions, 2015–2016

List of Figures (44 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Immunoassay Market: Bottom-Up Approach
Figure 4 Immunoassay Market: Top-Down Approach
Figure 5 Global Immunoassay Market: Data Triangulation Methodology
Figure 6 Reagents and Kits Segment to Account for the Largest Market Share in 2016
Figure 7 ELISA Segment to Dominate the Immunoassay Market in 2016
Figure 8 Infectious Diseases Segment to Dominate the Global Immunoassay Market in 2016
Figure 9 Hospital Segment to Account for the Largest Share of the Immunoassay Market in 2016
Figure 10 Asia to Witness the Highest Growth Rate in the Forecast Period
Figure 11 Rising Incidences of Chronic & Infectious Diseases and Technological Advancements to Drive Market Growth of the Immunoassay Market
Figure 12 Reagents & Kits to Command the Largest Market Share in 2016
Figure 13 ELISA is Expected to Dominate the Immunoassay Market in 2016
Figure 14 The U.S. is Expected to Dominate the Immunoassay Market in 2016
Figure 15 The Infectious Diseases Segment is Poised to Grow at the Highest Rate During the Forecast Period
Figure 16 Hospitals Will Dominate the Immunoassay Market By 2021
Figure 17 Asia to Witness Highest Growth in the Forecast Period
Figure 18 Incidence of Infectious Diseases, Per 100,000 Population in the U.S.
Figure 19 Incidence of the Top Ten Cancers, Per 100,000 Population, Globally
Figure 20 Western Blot Segment to Hold the Fastest Growing Market During the Forecast Period
Figure 21 Reagents & Kits Segment Hold Largest Market Share in 2016
Figure 22 ELISA Segment to Hold the Largest Market Share in 2016
Figure 23 The Infectious Diseases Application Segment is Expected to Dominate the Immunoassay Applications Market During the Forecast Period
Figure 24 Global Cancer Incidence, By Region, 2012 vs 2015 vs 2020
Figure 25 Hospitals Segment to Hold Largest Market Share in 2016
Figure 26 Emerging Economies Such as China, India, and Japan Offer Significant Growth Opportunities for Players in the Immunoassay Market
Figure 27 North America: Immunoassay Market Snapshot
Figure 28 ELISA Dominates the Technology Segment in the North American Market in 2016
Figure 29 Europe: Immunoassay Market Snapshot
Figure 30 Asia: Immunoassay Market Snapshot
Figure 31 RoW: Immunoassay Market Snapshot
Figure 32 Agreements, Collaborations, and Partnerships Was the Key Growth Strategy Adopted By Players in the Immunoassay Market
Figure 33 Immunoassay Market Share Analysis, By Key Player, 2015
Figure 34 Battle for Market Share: Agreements, Partnerships, and Collaborations–Key Growth Strategy Adopted Between 2014 & 2016
Figure 35 Product Benchmarking for Top 5 Players
Figure 36 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 37 Danaher Corporation: Company Snapshot
Figure 38 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 39 Siemens AG: Company Snapshot
Figure 40 Sysmex Corporation: Company Snapshot
Figure 41 Biomιrieux Sa: Company Snapshot
Figure 42 Alere Inc.: Company Snapshot
Figure 43 Becton, Dickinson and Company: Company Snapshot
Figure 44 Abbott Laboratories, Inc.: Company Snapshot

The global immunoassay market consists of various products that are used by hospitals, clinical laboratories, blood banks, research and academic laboratories, and pharmaceutical companies. The market is expected to reach USD 25.45 Billion by 2021 from USD 17.16 Billion in 2016 at a CAGR of 8.2%. This market is segmented based on product & service, technology, application, end user, and region.

The major factors driving the growth of this market are rising incidence of chronic diseases, extensive use of immunoassay in oncology, technological advancements, and cost-effectiveness & rapid analysis of immunoassay. However, the low detection limits of immunoassay, implementation of excise duty by the U.S. government, stringent regulations, and intellectual property rights issues are expected to restrain the market growth.

On the basis of product and service, the market is segmented into reagents & kits, analyzers, and software & services. The reagents & kits segment is expected to account for the largest share of the global market in 2016. This segment is further divided into ELISA, rapid tests reagents, western blot reagents, ELISPOT, RIA, and PCR. The analyzers segment is further divided into purchase mode and type. On the basis of purchase mode, the analyzers market is categorized into reagent rental purchase and outright purchase and on the basis of type into open-end systems and closed-ended systems.

Based on technology, the immunoassay market is segmented into ELISA, rapid tests, western blot tests, ELISPOT, radioimmunoassay (RIA), and polymerase chain reaction (PCR). ELISA is further divided by platform and generation. On the basis of platform, the ELISA market is segmented into CLIA, FIA, and CI. On the basis of generation, the ELISA market is further divided into first generation, second generation, third generation, and fourth generation & above.

On the basis of application, the market is segmented into infectious diseases, endocrinology, bone and mineral disorders, oncology, cardiology, hematology and blood screening, autoimmune diseases, toxicology, neonatal screening, and other applications.

On the basis of end user, the market is segmented into hospitals, clinical laboratories, blood banks, research & academic laboratories, pharmaceutical companies, CROs, biotechnology companies, and other end users.

The global immunoassay market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centred at China, Japan, and India.

The major players in this market include F. Hoffmann-La Roche Ltd. (Switzerland), Siemens AG (Germany), Abbott Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Ortho-Clinical Diagnostics, Inc. (U.S.), and bioMιrieux SA (France).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst